Fortress Biotech (NASDAQ:FBIO – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Monday. Several other research firms have also recently weighed in on FBIO. Alliance Global Partners initiated coverage on shares of Fortress Biotech in a research report […]

Related Keywords

Roth Mkm , Gladstone Institutional Advisory , Alliance Global Partners , Virtu Financial , Wealth Management Partners , Fortress Biotech Inc , Fortress Biotech Company Profile , Fortress Biotech , Get Free Report , Global Partners , Institutional Advisory , Management Partners , Fortress Biotech Daily ,